Drugmaker Idorsia is confident its cash reserves are large enough to complete development of its late-stage pipeline, it said on Tuesday, despite losing more than a quarter of a billion Swiss francs in the first nine months of the year.
from Reuters: Health https://ift.tt/2D3umxA
via
IFTTT
0 comments: